Pseudomonas aeruginosa is a major pathogen in healthcare-associated pneumonia (HCAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP). Its intrinsic resistance mechanisms, adaptive survival strategies, and
Pseudomonas aeruginosa pneumonia is a severe lower respiratory tract infection caused by a highly virulent gram-negative bacterium. Predominantly observed in healthcare settings, it is a
Nosocomial Pneumonia Due to Streptococcus pneumoniae: Nosocomial pneumonia, commonly referred to as hospital-acquired pneumonia (HAP), is an infection of the lung parenchyma that occurs 48
Nosocomial Pneumonia Due to Serratia marcescens: Nosocomial pneumonia, also referred to as hospital-acquired pneumonia (HAP), is a serious and potentially fatal infection occurring 48 hours
Nosocomial Pneumonia Due to Escherichia coli: Nosocomial pneumonia due to Escherichia coli represents a significant burden in hospital settings, particularly among critically ill and immunocompromised
Nosocomial bacterial pneumonia—commonly referred to as hospital-acquired pneumonia (HAP)—is a severe respiratory infection that develops 48 hours or more after hospital admission. A subset of
Klebsiella nosocomial pneumonia is a serious hospital-acquired infection caused by Klebsiella pneumoniae, a gram-negative bacterium. It is a leading cause of ventilator-associated pneumonia (VAP) in